KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardant Health (GH) Net Margin (2017 - 2025)

Guardant Health (GH) has disclosed Net Margin for 9 consecutive years, with 45.68% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 932.0% to 45.68% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 42.39% through Dec 2025, up 1666.0% year-over-year, with the annual reading at 42.39% for FY2025, 1666.0% up from the prior year.
  • Net Margin hit 45.68% in Q4 2025 for Guardant Health, down from 34.96% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 34.96% in Q3 2025 to a low of 210.21% in Q2 2022.
  • Historically, Net Margin has averaged 88.76% across 5 years, with a median of 76.17% in 2024.
  • Biggest five-year swings in Net Margin: tumbled -10427bps in 2022 and later skyrocketed 15715bps in 2023.
  • Year by year, Net Margin stood at 84.09% in 2021, then plummeted by -31bps to 110.28% in 2022, then decreased by -9bps to 120.63% in 2023, then soared by 54bps to 55.0% in 2024, then rose by 17bps to 45.68% in 2025.
  • Business Quant data shows Net Margin for GH at 45.68% in Q4 2025, 34.96% in Q3 2025, and 43.04% in Q2 2025.